Bildkälla: Stockfoto

Lifeclean Q4’21: No take off – Yet - Redeye

Redeye saw slightly slower development than expected in Q4. Sequentially the sales uptake continues to be slower than expected given the strong partnerships and product quality, even if the difference is not material. We lower our estimates for the 2022E while adjusting our Base case value only slightly downward.

Redeye saw slightly slower development than expected in Q4. Sequentially the sales uptake continues to be slower than expected given the strong partnerships and product quality, even if the difference is not material. We lower our estimates for the 2022E while adjusting our Base case value only slightly downward.
Börsvärldens nyhetsbrev
ANNONSER